Related Experiment Video
Updated: Jan 30, 2026
12:42
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
15.7K
Detecting ovarian cancer using extracellular vesicles: progress and possibilities
Emanuela Carollo1, Bianca Paris1, Priya Samuel1
1Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Headington, Oxford OX3 0BP, U.K.
Biochemical Society Transactions
|February 1, 2019
Summary
Extracellular vesicles (EVs) show promise as biomarkers for early ovarian cancer (OC) detection. Research indicates EVs and their cargo can identify OC, potentially improving patient outcomes.
Area of Science:
- Gynecological Oncology
- Biomarker Discovery
- Extracellular Vesicles
Background:
- Ovarian cancer (OC) is a leading cause of gynecological cancer mortality, often diagnosed at advanced stages.
- Early detection significantly improves patient survival, but lacks effective clinical biomarkers.
- Extracellular vesicles (EVs), released by cells, carry molecular cargo reflecting their origin, making them potential diagnostic sources.
Purpose of the Study:
- To review recent advancements in using extracellular vesicles (EVs) as biomarkers for early ovarian cancer (OC) detection.
- To explore the potential of EV cargo, such as miRNAs and proteins, for OC diagnosis and prognosis.
Main Methods:
- Review of current scientific literature on extracellular vesicles (EVs) in ovarian cancer (OC).
- Analysis of studies investigating EV cargo (miRNAs, proteins) for OC detection and staging.
Main Results:
- EVs released by cancer cells contain altered molecular cargo, serving as potential biomarkers in biofluids.
- Studies demonstrate that EV-derived miRNAs and proteins can be utilized for OC detection.
- EVs may also provide insights into disease stage and predict therapeutic response.
Conclusions:
- Extracellular vesicles (EVs) represent a promising avenue for developing novel biomarkers for early ovarian cancer (OC) detection.
- Despite challenges, ongoing research in EVs holds significant potential for clinical diagnostic assays to improve patient outcomes.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
02:07Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
01:42The Extracellular Matrix
88.9K
Overview
88.9K
01:29The Extracellular Matrix
12.2K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.2K
01:27Ovarian Cycle
3.8K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.8K
01:30Hormonal Control of the Ovarian Cycle
6.9K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.9K